Fei Tang

Title: Innovations and Contributions of Inventor Fei Tang

Introduction

Fei Tang, based in Washington, DC, is a notable inventor in the field of biomedical research, specifically focusing on innovations related to cancer immunotherapy. With a total of three patents to his name, Tang's work emphasizes the development of immunotherapeutic strategies aimed at improving patient outcomes while minimizing adverse reactions.

Latest Patents

Fei Tang's latest innovations include the following significant patents:

1. **CD80 and CD86 binding protein compositions and uses thereof** - This patent pertains to CTLA-4 protein compositions and their application in mitigating autoimmune adverse events that may arise from cancer immunotherapy.

2. **Mutant anti-CTLA-4 antibodies with improved immunotherapeutic effect but attenuated adverse effects** - This invention outlines anti-CTLA-4 antibody compositions that specifically bind to the human CTLA-4 molecule, showcasing their effectiveness in cancer treatment alongside a reduced risk of autoimmune side effects when compared to other immunotherapeutic agents.

Career Highlights

Throughout his career, Fei Tang has collaborated with prestigious organizations, including Oncoc4, Inc. and Children's National Medical Center. His contributions in these roles have been instrumental in advancing cancer treatments and improving therapeutic methodologies.

Collaborations

Fei Tang has worked alongside esteemed coworkers such as Yang Liu and Pan Zheng. These collaborations enrich his innovative endeavors, fostering an environment where groundbreaking ideas and technologies can flourish in the domain of cancer immunotherapy.

Conclusion

As a dedicated inventor, Fei Tang continues to make significant advancements in the biomedical field through his innovative patents. His commitment to improving cancer treatment not only highlights his ingenuity but also reflects the potential for future advancements in medical therapies.